| 2023/10/04 18:53:37 | |
|---|---|
| Price | |
| 56.715 USD | |
| Difference | -0.88% (-0.51) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 114,189 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 56.71 USD (1,000) |
| Ask (Ask size) | 56.72 USD (400) |
| Open | 57.10 USD |
| High | 57.34 USD |
| Low | 56.55 USD |
| Close (prev. day) | 57.22 USD |
| VWAP | 56.78036 USD |
| Volume (pcs) | 4,081,736 |
| Trading volume | 231,761,131.38 |
| Number of trades | 45,172 |
| Last size | 100 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/09/29 |
|
Global Equity Ratings |
|
| 2023/09/08 |
|
Global Equity Ratings |
|
| 2023/08/22 |
|
Global Equity Ratings |
|
| 2023/08/17 |
|
Global Equity Ratings |
|
| 2023/08/09 |
|
Global Equity Ratings |
|
| 2023/10/04 18:53:37 | |
|---|---|
| Price | |
| 56.715 USD | |
| Difference | -0.88% (-0.51) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 114,189 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 56.71 USD (1,000) |
| Ask (Ask size) | 56.72 USD (400) |
| Open | 57.10 USD |
| High | 57.34 USD |
| Low | 56.55 USD |
| Close (prev. day) | 57.22 USD |
| VWAP | 56.78036 USD |
| Volume (pcs) | 4,081,736 |
| Trading volume | 231,761,131.38 |
| Number of trades | 45,172 |
| Last size | 100 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -17.89% | -18.87% | -2.55% |
| Perf (abs.) | -12.47 | -13.31 | -1.50 |
| Beta | 0.28 | 0.30 | 0.35 |
| Volatility | 16.94 | 18.00 | 19.64 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 57.828 USD (10,078,175) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 59.948 USD (10,873,988) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 62.640 USD (9,949,429) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 68.453 USD (9,020,206) |
| YTD High | date | 75.180 USD (2023/02/06) |
| YTD Low | date | 57.120 USD (2023/10/03) |
| 52 Weeks High | date | 81.435 USD (2022/12/01) |
| 52 Weeks Low | date | 57.120 USD (2023/10/03) |
All listings for BRISTOL-MYERS SQUIBB CO.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2023/10/04 | 17:35 | 53.90 EUR | 0.11 | 30 |
| Vienna Stock Exchange | 2023/10/04 | 17:32 | 53.90 EUR | 0.00 | 2 |
| Tradegate | 2023/10/04 | 18:16 | 54.00 EUR | 0.19 | 61 |
| Stuttgart | 2023/10/04 | 15:47 | 54.10 EUR | 0.02 | 5 |
| SIX Swiss Exchange | 2019/06/28 | 17:35 | 44.39 CHF | 0.00 | 1 |
| SIX Swiss Exchange | 2019/07/03 | 05:55 | 45.30 USD | 0.00 | 1 |
| NYSE | 2023/10/04 | 18:53 | 56.715 USD | 231.76 | 45,172 |
| Munich | 2023/10/04 | 08:01 | 54.80 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2023/10/04 | 17:30 | 57.85 USD | 0.00 | 2 |
| Hanover | 2023/10/04 | 08:01 | 54.60 EUR | 0.00 | 1 |
| Hamburg | 2023/10/04 | 08:01 | 54.60 EUR | 0.00 | 1 |
| Frankfurt | 2023/10/04 | 16:29 | 54.10 EUR | 0.01 | 5 |
| Duesseldorf | 2023/10/04 | 16:30 | 54.10 EUR | 0.00 | 4 |
| Berlin | 2023/10/04 | 08:02 | 54.60 EUR | 0.00 | 1 |
| BX Swiss | 2023/08/07 | 18:00 | 52.787 CHF | 0.00 | 1 |
Company Logo
Contact Details
| BRISTOL MYERS SQUIBB CO. |
| - - |
| Route 206 & Province Line Road - 08543 Princeton |
| Telefon: +1-212-546-4000 |
| Fax: + |
| E-mail: media@bms.com |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. | |
Company Profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in Princeton, NJ. |
Members of Management Board
| Christopher Boerner | Member of Board of Directors |
| Deepak Bhatt | Member of Board of Directors |
| Julia Haller | Member of Board of Directors |
| Karen Vousden | Member of Board of Directors |
| Manuel Hidalgo Medina | Member of Board of Directors |
| Derica Rice | Member of Board of Directors |
| Gerald Storch | Member of Board of Directors |
| Paula Price | Member of Board of Directors |
| Peter Arduini | Member of Board of Directors |
| Phyllis Yale | Member of Board of Directors |
| Theodore Samuels | Member of Board of Directors |
| Giovanni Caforio | Chairman of Managing Board |
| Christopher Boerner | Member of Executive Committee |
| Adam Dubow | Member of Executive Committee |
| Ann M. Powell | Member of Executive Committee |
| Catalina Vargas | Member of Executive Committee |
| David Elkins | Member of Executive Committee |
| Elizabeth A. Mily | Member of Executive Committee |
| Lou Schmukler | Member of Executive Committee |
| Michelle Weese | Member of Executive Committee |
| Paul von Autenried | Member of Executive Committee |
| Rupert Vessey | Member of Executive Committee |
| Samit Hirawat | Member of Executive Committee |
| Sandra Leung | Member of Executive Committee |